...
首页> 外文期刊>Rheumatology >Identification of novel autoantibodies to GABAB receptors in patients with neuropsychiatric systemic lupus erythematosus
【24h】

Identification of novel autoantibodies to GABAB receptors in patients with neuropsychiatric systemic lupus erythematosus

机译:神经精神性系统性红斑狼疮患者中针对GABA B受体的新型自身抗体的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The gamma-aminobutyric acid type B receptors (GABARB) are G-protein coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. We identified GABARB subunits as candidate antigens in patients with SLE using a random peptide display library. The aim of this study was to investigate the possible link between anti-GABARB antibodies and disease activity and NPSLE. Methods: ELISA was performed with recombinant proteins of GABARB1b and GABARB2 on serum samples from patients with SLE (n = 88), scleroderma (n = 20), myositis (n = 20) or vasculitis (n = 20) as well as healthy subjects (n = 20). Cerebrospinal fluid (CSF) from 23 patients with SLE was also examined. Results: Autoantibodies to GABARBs were exclusive to patients with SLE (P0.001) and positively associated with SLEDAI (anti-GABARB1b, P = 0.001; anti-GABARB2, P0.001). Of note, autoantibodies were positively linked with NPSLE (anti-GABARB1b, P = 0.02; anti-GABARB2, P = 0.03). Moreover, anti-GABARBs was detected in 61.5% of CSF samples from patients with active NPSLE, a frequency that was significantly higher than that for patients with non-SLE syndromes. Conclusion: Anti-GABARB antibodies could represent novel candidate markers for disease activity and NPSLE.
机译:目的:γ-氨基丁酸B型受体(GABARB)是GABA的G蛋白偶联受体,GABA是大脑中主要的抑制性神经递质。我们使用随机肽展示库确定了SABA患者的GABARB亚基为候选抗原。这项研究的目的是研究抗GABARB抗体与疾病活性和NPSLE之间的可能联系。方法:对患有SLE(n = 88),硬皮病(n = 20),肌炎(n = 20)或血管炎(n = 20)以及健康受试者的血清样本中的GABARB1b和GABARB2重组蛋白进行ELISA (n = 20)。还检查了23例SLE患者的脑脊液(CSF)。结果:针对GABARB的自身抗体仅适用于SLE患者(P <0.001),并且与SLEDAI正相关(抗GABARB1b,P = 0.001;抗GABARB2,P <0.001)。值得注意的是,自身抗体与NPSLE正相关(抗GABARB1b,P = 0.02;抗GABARB2,P = 0.03)。此外,在活动性NPSLE患者的脑脊液样本中有61.5%检出了抗GABARBs,其频率明显高于非SLE综合征患者。结论:抗GABARB抗体可以代表疾病活性和NPSLE的新候选标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号